ENTITY
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals (REGN US)

119
Analysis
Health CareUnited States
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
more
Refresh
Company Presentation02 Nov 2023 20:30
Company Presentation04 May 2023 20:30
Company Presentation03 Nov 2022 20:30
Company Presentation03 Aug 2022 09:06
Company Presentation04 May 2022 17:12
x